Ozempic in Spain: what it is, how it works and who can take it

Introduction

Ozempic is probably the medicine you have heard most about over the past two years. It comes up in office conversations, in newspaper headlines, in social media threads. And yet much of the information circulating about it is imprecise, contradictory or simply wrong.

This guide answers, with clinical rigour, the questions that really matter about Ozempic in Spain: what it actually is, how it works in the body, who is a candidate for it, how to obtain it legally, what risks it carries and what alternatives exist. All the information is up to date as of 2026 and has been reviewed by Dr David Céspedes, Medical Director of AiON.

What Ozempic is: the product information in plain language

Ozempic® is the brand name for semaglutide, a molecule developed by the Danish pharmaceutical company Novo Nordisk. Technically it belongs to a class of drugs called GLP-1 receptor agonists, which means it mimics the effect of a hormone the human body produces naturally (glucagon-like peptide-1, or GLP-1).

Semaglutide is given as a weekly subcutaneous injection, usually into the abdomen, thigh or arm, using a pre-filled pen device that makes self-administration straightforward.

From a regulatory point of view, Ozempic has been authorised in the European Union by the European Medicines Agency (EMA) since 2018, and in Spain by the AEMPS. Its officially authorised indication is the treatment of type 2 diabetes mellitus in adults, alongside diet and exercise, when blood glucose control is not achieved with other treatments.

Ozempic and weight loss: off-label use

Although Ozempic is officially authorised for type 2 diabetes, clinical trials showed that patients with diabetes who took it experienced significant weight loss as an additional effect. This finding led Novo Nordisk to develop a second medicine with the same active ingredient (semaglutide) but at higher doses, specifically indicated for weight loss: Wegovy®.

In Spain, the key difference is:

• Ozempic: authorised for type 2 diabetes. Maximum dose of 1 mg per week.
• Wegovy: authorised for obesity and for overweight with comorbidities. Maximum dose of 2.4 mg per week.

Using Ozempic for weight loss in patients without diabetes is considered off-label use (outside the authorised indication). This means a doctor may prescribe it under their own clinical responsibility in certain circumstances, but it is not covered by the Spanish public health system and requires documented clinical justification.

How Ozempic works in the body

Semaglutide acts on several systems at once, which explains why it is so effective both for blood glucose control and for reducing body weight.

Action on the pancreas

It stimulates insulin secretion only when blood glucose levels are raised. This lowers the risk of hypoglycaemia compared with other diabetes medications. At the same time, it suppresses the release of glucagon, the hormone that raises glucose levels.

Action on the stomach

It slows gastric emptying, which prolongs the feeling of fullness after meals. Patients on treatment report feeling full with smaller portions and taking longer to feel hungry again.

Action on the brain

It acts directly on receptors in the hypothalamus involved in regulating appetite and the sensation of hunger. This central mechanism is key to the reduction in body weight and explains why patients describe a genuine drop in obsessive thoughts about food, popularly known as food noise.

Clinical profiles suited to Ozempic

Prescribing Ozempic requires an individual medical assessment. Not every patient is a candidate, and some conditions rule it out completely. The profiles in which clinical evidence supports its use include:

• Patients with type 2 diabetes not controlled with metformin and other oral diabetes medications.
• Patients with type 2 diabetes and high cardiovascular risk, given that Ozempic has been shown to reduce major adverse cardiovascular events.
• Patients with obesity (BMI ≥ 30) or overweight with comorbidities (BMI ≥ 27 with high blood pressure, dyslipidaemia, sleep apnoea, etc.), although for this profile the officially indicated medicine is Wegovy, not Ozempic.

Absolute contraindications

• A personal or family history of medullary thyroid carcinoma.
• Multiple endocrine neoplasia type 2 (MEN 2) syndrome.
• Known hypersensitivity to semaglutide or to any of the excipients.
• Pregnancy and breastfeeding.
• Active acute or chronic pancreatitis.

Profiles that need particularly careful assessment

• Patients with kidney or liver disease.
• Patients with advanced diabetic retinopathy.
• Patients with a history of pancreatitis or gallbladder disease.
• Patients with active eating disorders.

How to obtain Ozempic legally in Spain

Ozempic is a prescription-only medicine. This means that:

• It cannot be obtained without a prescription issued by an authorised healthcare professional.
• It cannot be sold online without a prescription. Any website offering Ozempic without a prescription is operating illegally and the product may be counterfeit.
• It must be dispensed by legally authorised pharmacies.

The legitimate routes of access are:

Through the public health system

Only for patients with type 2 diabetes who meet specific inclusion criteria within the services covered by the Spanish National Health System. The GP or endocrinologist assesses suitability and issues a publicly funded electronic prescription.

Through a face-to-face private consultation

The patient sees a private endocrinologist, undergoes a full clinical assessment and, if the doctor considers the treatment appropriate, receives a private electronic prescription to be dispensed at a pharmacy. The cost covers the consultation plus the medication, paid for by the patient.

Through private telemedicine with a registered doctor

An emerging model that allows an online consultation with a doctor registered in Spain, clinical assessment through a structured questionnaire and video call, and, where appropriate, the issuing of a private electronic prescription that the patient collects at their usual pharmacy. This model is only legitimate if the prescribing doctor is registered in Spain with a verifiable registration number.

What to look for in a supervised medical programme

If you are considering starting treatment with Ozempic or any other GLP-1 receptor agonist, it is worth assessing the medical programme you turn to carefully. The features that set a serious medical programme apart are:

• An identifiable prescribing doctor, with a registration number that can be verified in the Spanish register of licensed doctors.
• A relevant medical speciality: endocrinology, preventive medicine, internal medicine, or general practice with specific training in obesity.
• A full clinical assessment before prescribing, including medical history, up-to-date blood tests and a review of contraindications.
• Gradual dose titration over the first few weeks to minimise side effects.
• Ongoing medical follow-up, ideally monthly, to adjust the dose and assess response.
• Accessible support to answer questions or manage side effects between appointments.
• A complementary nutrition plan and supplementation advice appropriate to the calorie deficit.

Conclusion

Ozempic is an effective medicine with solid clinical evidence behind the indications for which it is authorised. But it is not a consumer product, nor a magic solution. It is a prescription-only drug for important clinical reasons: it has real contraindications, side effects that are manageable but genuine, and its effectiveness depends critically on being used under appropriate medical supervision.

Before considering any drug treatment for weight loss, the clinical recommendation is to see a specialist endocrinologist who can assess your individual case, review your full history, take your particular circumstances into account and design the plan best suited to your profile.

Are you considering a medical approach to your weight loss?

Peso is a comprehensive medical programme designed precisely to offer professional, safe access to bariatric medicine. Our medical team, supervised by Medical Director Dr David Céspedes, assesses your individual case in under 24 hours and designs a personalised plan based on your clinical profile. If you are not a candidate, there is no charge.

Start your medical assessment

Frequently asked questions

Can you buy Ozempic without a prescription in Spain?

No. Ozempic is a prescription-only medicine. Dispensing it without a prescription is illegal, and websites that offer it without one are operating outside the law. What is more, product bought through unofficial channels may be counterfeit or poorly stored.

How much does Ozempic cost in Spain?

The price varies according to the dose and whether the medicine is publicly funded or not. With a private prescription, the cost is roughly 120 to 200 euros per monthly pen, depending on the presentation. Where it is funded by the public health system for type 2 diabetes, the patient pays only the corresponding co-payment.

How much weight do you lose on Ozempic?

Weight loss varies and depends on the patient, the dose, how long treatment lasts and the accompanying lifestyle changes. Clinical trials with semaglutide show average losses of between 10% and 15% of initial body weight after 68 weeks of supervised treatment.

What happens when you stop taking Ozempic?

Studies show that after stopping treatment there is partial regain of the weight lost if lifestyle changes are not maintained. That is why ongoing medical follow-up and the nutrition plan matter just as much as the medication itself.

Can I take Ozempic just to lose weight if I do not have diabetes?

That decision rests entirely with a doctor. For weight loss without diabetes, the officially indicated medicine in Spain is Wegovy, not Ozempic. A doctor may prescribe Ozempic off-label at their clinical discretion in certain circumstances, but this requires documented justification and close follow-up.

Your next step

If you have read this far, the underlying question is no longer "Ozempic, yes or no": it is whether medical weight-loss treatment is right for you — and that decision belongs to a doctor with your case in front of them. Medical weight-loss treatment is now available in Spain, with a prior assessment, a prescription where appropriate from a registered doctor, and ongoing follow-up from the medical team. You can check whether you are eligible in 30 seconds.

Legal notice

This content is for information and general education. It is in no way a substitute for professional medical advice, diagnosis or treatment. The medicines mentioned in this article are prescription-only drugs that can be dispensed only with an official prescription issued by an authorised healthcare professional. Always consult an endocrinologist before starting any weight-loss treatment.